Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 701-705

  Palmer, Shirley M ^a,d   Rybak, Michael J ^a,b,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DETROIT RECEIVING HOSPITAL   (United States)

^d UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN; RIFAMPICIN; VANCOMYCIN;

ARTICLE; BACTERIAL ENDOCARDITIS; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG MIXTURE; FIBRIN CLOT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THROMBOCYTE AGGREGATION;

EID: 0030048092     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.701     Document Type: Article

References (25)

1. Blaser, J. 1985. In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives. J Antimicrob. Chemother. 15(Suppl. A):125-130.
2. Chambers, H. F., R. T. Miller, and M. D. Newman. 1988. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann. Intern. Med. 109:619-624.
3. Cremieux, A. C., and C. Carbon. 1992. Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis. Antimicrob Agents Chemother. 36:2069-2074.
4. Cremieux, A. C., B. Maziere, J. M. Vallois, M. Ottaviani, A. Azancot, H. Raffoul, A. Bouvet, J. J. Pocidalo, and C. Carbon. 1989. Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. J. Infect. Dis. 159:938-944.
5. Cremieux, A. C., A. Saleh-Mgir, J. M. Vallois, B. Maziere, M. Ottaviani, J. J. Pocidalo, and C. Carbon. 1991 Pattern of diffusion of three quinolones throughout infected cardiac vegetations studied by autoradiography. abstr. 357. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington. D.C.
6. Drusano, G. L., D. E. Johnson, M. Rosen, and H. C. Standiford. 1993. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of pseudomonal sepsis. Antimicrob. Agents Chemother. 37:483-490.
7. Eliopoulos, G. M., and R. C. Moellering, Jr. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine. 3rd ed The Williams & Wilkins Co.. Baltimore.
8. Fu, K. P., S. C. Lafredo, B. Foleno, D. M. Isaacson, J. F. Barrett, A. J. Tobia, and M. E. Rosenthale. 1992. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin). an optically active ofloxacin. Antimicrob. Agents Chemother. 36:860-866
9. Hackbarth, C. J., H. F. Chambers, and M. A. Sande. 1986. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrob. Agents Chemother. 29:611-613.
10. Henry, N. K., M. S. Rouse, A. L. Whitesell, M. E. McConnell, and W. R. Wilson. 1987. Treatment of methicillin-resistant Staphylococcus aureas experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin Am. J. Med. 82(Suppl 4A):73-75.
11. Kaatz, G. W., S. L. Barriere, D. R. Schaberg, and R. Fekety. 1987. The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis J. Antimicrob. Chemother. 20:753-758.
12. Kaatz, G. W., S. M. Seo, S. L. Barriere, L. M. Albrecht, and M. J. Rybak. 1989. Ciprofloxacin and rifampin. alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother 33:1184-1187.
13. Kaatz, G. W., S. M. Seo, S. L. Barriere, L. M. Albrecht, and M. J. Rybak. 1990. Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother. 34:257-260.
14. Kang, S. L., M. J. Rybak, B. J. McGrath, G. W. Kaatz, and S. M. Seo. 1994. Pharmacodynamics of levofioxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model. Antimicrob. Agents Chemother. 38:2702-2709.
15. Levine, D. P., B. S. Fromm, and B. R. Reddy. 1991. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115:674-680
16. Lewin, C. S., and J. T. Smith. 1988. Bactericidal mechanisms of ofloxacin. J. Antimicrob. Chemother. 22(Suppl. C):1-8.
17. 14C-clavulanic acid throughout infected cardiac vegetations studied by autoradiography, abstr. 699. In Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
18. McGrath, B. J., S. L. Kang, G. W. Kaatz, and M. J. Rybak. 1994. Bactericidal activities of teicoplanin. vancomycin. and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis. Antimicrob. Agents Chemother. 38:2034-2040
19. National Committee for Clinical Laboratory Standards. 1990. Approved standard. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS document M7-A. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. Rocci, M. L., Jr., and W. J. Jusko. 1983. LAGRAN program version 2.1 for area and moments in pharmacokinetic analysis. Comput. Programs Biomed. 16:203-216
21. Rybak, M. J., L. M. Albrecht, J. R. Berman, L. H. Warbasse, and C. K. Svensson. 1990. Vancomycin pharmacokinetics in burn patients and intravenous drug users Antimicrob. Agents Chemother. 34:792-795.
22. Siedentop, K. H., D. M. Harris, K. Ham, and B. Sanchez. 1986. Extended experimental and preliminary surgical findings with autologous fibrin tissue adhesive made from patient's own blood. Laryngoscope 96:1062-1064.
23. Small, P. M., and H. F. Chambers. 1990 Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob. Agents Chemother. 34:1227-1231.
24. Thompson, D. F., N. A. Letassy, and G. D. Thompson. 1988. Fibrin glue: a review, of its preparation, efficacy, and adverse effects as a topical hemostat. Drug Intell. Clin. Pharm 22:946-952.
25. Zinner, S. H., H. Lagast, and J. Klastersky. 1981. Antistaphylococcal activity of rifampin with other antibiotics. J. Infect. Dis. 144:365-371